IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 143 filers reported holding IMMUNITYBIO INC in Q4 2021. The put-call ratio across all filers is 4.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,801,912 | -13.7% | 14,675,687 | +42.0% | 0.00% | 0.0% |
| Q2 2023 | $28,726,578 | +90.5% | 10,333,301 | +24.7% | 0.00% | – |
| Q1 2023 | $15,080,444 | -64.0% | 8,285,958 | +0.4% | 0.00% | -100.0% |
| Q4 2022 | $41,854,098 | +4.2% | 8,255,246 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $40,155,000 | +43.5% | 8,079,541 | +7.4% | 0.00% | 0.0% |
| Q2 2022 | $27,983,000 | -30.3% | 7,522,377 | +5.1% | 0.00% | 0.0% |
| Q1 2022 | $40,146,000 | -7.5% | 7,156,146 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $43,403,000 | -36.6% | 7,138,537 | +1.5% | 0.00% | -50.0% |
| Q3 2021 | $68,484,000 | -13.7% | 7,031,258 | +26.5% | 0.00% | 0.0% |
| Q2 2021 | $79,398,000 | +30.7% | 5,560,023 | +117.2% | 0.00% | 0.0% |
| Q1 2021 | $60,761,000 | – | 2,559,391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 226,916 | $383,488 | 0.76% |
| HARBOURVEST PARTNERS LLC | 335,709 | $567,348 | 0.19% |
| ALLEN HOLDING INC /NY | 687,571 | $1,161,995 | 0.16% |
| ARMISTICE CAPITAL, LLC | 3,476,000 | $5,874,440 | 0.09% |
| Clearwater Capital Advisors, LLC | 394,599 | $666,873 | 0.08% |
| SHEETS SMITH WEALTH MANAGEMENT | 273,879 | $462,856 | 0.07% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $162,972 | 0.06% |
| WEALTH EFFECTS LLC | 53,500 | $90,415 | 0.04% |
| Virtus ETF Advisers LLC | 34,461 | $58,239 | 0.04% |
| FISHMAN JAY A LTD/MI | 162,000 | $273,780 | 0.04% |